Cooperativity Principles in Self-Assembled Nanomedicine

Total Page:16

File Type:pdf, Size:1020Kb

Cooperativity Principles in Self-Assembled Nanomedicine Review Cite This: Chem. Rev. 2018, 118, 5359−5391 pubs.acs.org/CR Cooperativity Principles in Self-Assembled Nanomedicine † † ‡ † † Yang Li, Yiguang Wang, , Gang Huang, and Jinming Gao*, † Department of Pharmacology, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States ‡ Beijing Key Laboratory of Molecular Pharmaceutics and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, 100191, China ABSTRACT: Nanomedicine is a discipline that applies nanoscience and nano- technology principles to the prevention, diagnosis, and treatment of human diseases. Self-assembly of molecular components is becoming a common strategy in the design and syntheses of nanomaterials for biomedical applications. In both natural and synthetic self-assembled nanostructures, molecular cooperativity is emerging as an important hallmark. In many cases, interplay of many types of noncovalent interactions leads to dynamic nanosystems with emergent properties where the whole is bigger than the sum of the parts. In this review, we provide a comprehensive analysis of the cooperativity principles in multiple self-assembled nanostructures. We discuss the molecular origin and quantitative modeling of cooperative behaviors. In selected systems, we describe the examples on how to leverage molecular cooperativity to design nanomedicine with improved diagnostic precision and therapeutic efficacy in medicine. CONTENTS 4.2.2. Tunable Sol−Gel Transition Temperature 5367 4.3. Thermoresponsive Elastin Like Polypeptides 1. Introduction 5360 (ELPs) 5368 2. Conformation Change-Induced Cooperativity in 4.3.1. Cooperativity in Supramolecular Self- Natural Self-Assembled Nanostructures 5360 Assembly of ELPs 5368 2.1. Self-Organization of Protein and RNA 5360 4.3.2. Tunable Phase Transition Temperature 2.1.1. Protein Folding 5360 of ELPs 5368 2.1.2. Nucleic Acid Folding 5361 4.4. Ultra-pH Sensitive (UPS) Nanoparticles 5370 2.2. Allosteric Cooperativity 5361 4.4.1. Cooperativity in Reversible Protonation 2.2.1. Hemoglobin-Oxygen Binding 5361 of UPS Block Copolymers 5371 2.2.2. Cooperative Enzyme Catalysis 5361 4.4.2. Tunable pKa and pH Transition Sharp- 2.3. Multivalent Cooperativity and Molecular ness 5371 Recognition 5362 4.5. pH-(Low) Insertion Peptides (pHLIPs) 5372 2.4. Biomolecular Condensation and Phase Tran- 5. Molecular Mechanism of Supramolecular Coop- sition-Induced Cooperativity 5362 erativity 5373 3. Noncovalent Interactions: Molecular Basis of 5.1. Origin of Cooperativity 5374 Downloaded via UNIV OF TEXAS SW MEDICAL CTR on March 15, 2019 at 19:43:29 (UTC). Supramolecular Cooperativity 5363 See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. 5.1.1. Cooperative Folding of Proteins 5374 3.1. Hydrophobic Interaction 5363 5.1.2. Cooperative Activation of Ion Channels 5375 3.2. Hydrogen Bonding 5364 5.1.3. Cooperative Dehydration of Thermores- 3.3. Electrostatic Interaction 5364 π−π ponsive Polymers 5375 3.4. Stacking 5364 5.1.4. Hydrophobic Micellization-Driven Coop- 3.5. Cooperativity: Interplay of Noncovalent In- erative Protonation 5375 teractions 5364 5.2. Quantitative Analysis of Cooperativity 5375 4. Phase Transition-Induced Cooperativity in Syn- 6. Supramolecular Cooperativity in Addressing the thetic Self-Assembled Nanostructures 5364 Challenges in Medicine 5378 4.1. Oligonucleotides-Conjugated Gold Nanopar- 6.1. Targeted Drug Delivery 5378 ticles 5364 6.2. Biological Sensing and Molecular Imaging 5378 4.1.1. Cooperativity in Aggregation of Oligo- 6.3. Digitization of pH Signals by Threshold nucleotides-Conjugated Nanoparticles 5365 Sensors 5379 4.1.2. Tunable Phase Transition Temperature 5365 6.4. On Demand Drug Release 5379 4.2. Poly(acrylamide)-Based Thermoresponsive Hydrogels 5366 4.2.1. Cooperativity in Gelation of Thermores- Received: March 27, 2018 ponsive Polymers 5367 Published: April 25, 2018 © 2018 American Chemical Society 5359 DOI: 10.1021/acs.chemrev.8b00195 Chem. Rev. 2018, 118, 5359−5391 Chemical Reviews Review 7. Summary and Future Perspective 5380 Author Information 5382 Corresponding Author 5382 ORCID 5382 Notes 5382 Biographies 5382 Acknowledgments 5382 References 5382 1. INTRODUCTION Nanomaterials are rapidly evolving and impact a broad range of − applications in photonics, electronics, and medicine.1 6 In particular, they play an increasingly important role in medicine, where numerous nanosystems have been developed for biochemical sensing, molecular imaging, disease diagnosis, and − treatment.7 12 Various nanoplatforms have been extensively investigated to address challenges in medicine to overcome deficiencies in conventional small molecular sensors and drugs, resulting in the rapid growth of nanomedicine as a new − discipline.13 15 In contrast to “top-down” methods like lithography, a Figure 1. Supramolecular self-assembly for the development of “bottom-up” approach allows the formation of nanoscopic cooperative nanomedicine. architectures driven by noncovalent self-assembly of molecular 16−18 components. Self-assembly, which bridges the structures of molecules.25 The binding may display either positive or negative individual building blocks and the function of the obtained 19 cooperativity. Positive cooperativity is described as synergistic nanocomplex, is an essential part of nanotechnology. The (whole is bigger than the sum of the parts) and negative underlying supramolecular chemistry principles were described 26 20,21 cooperativity as interfering. In this section, we begin the by Lehn and Whitesides over two decades ago. Compared to discussion of biological cooperativity using well-established covalent chemistry, noncovalent self-assembly employs weak and protein/RNA folding and allosteric examples (e.g., hemoglo- polyvalent interactions to achieve a thermodynamically stable bin-O2 interactions), then move on to more complex multivalent nanostructure. This strategy can produce nanoscopic structures cell surface interactions, and finally present the emerging 4− 10 (10 10 Da) that are not easily synthesizable by covalent microphase separations of large protein signaling complexes. chemistry. The resulting system often has a faster temporal 2.1. Self-Organization of Protein and RNA response to environmental stimuli due to the lower energy fi barrier (e.g., dissociation of noncovalent complexes requires 2.1.1. Protein Folding. Adening characteristic of bio- lower energy than breaking of covalent bonds).22,23 logical systems is their capability to organize small molecular A hallmark of self-assembled systems is molecular coopera- components into supramolecular structures with extraordinary 21 fi tivity, where the system behaves quite differently as a whole precision and delity. Protein folding, where a polypeptide chain self-organizes into a perfectly folded three-dimensional structure, from the sum of parts acting in isolation. Positive cooperativity 27 has been identified in many biological and physiological is a great example. A newly synthesized chain of amino acids processes (e.g., oxygen transport by hemoglobin).24 Mechanistic can form multiple structured assemblies, such as secondary/ investigations on several established self-assembled nanosystems tertiary structures and macromolecular complexes. The pop- ff also suggest that positive cooperativity contributes to enhanced ulations and interconversion of di erent assemblies are governed detection sensitivity and specificity in chemical and biological by thermodynamic and kinetic stabilities. 5 fi sensing. Understanding the supramolecular self-assembly Cooperativity is observed in the nal folding step of proteins ff when the side-chains are locked in the native state and water process and associated cooperativity o ers a new paradigm for 28,29 the design and development of nanomaterials in medicine. molecules are squeezed out of the hydrophobic protein core. In this article, we highlight the recent advances in the The Onuchic group used a minimalist model to search for the intermediate states leading to the native structure in parallel with investigation of cooperativity principles underlying the design of 29 self-assembled nanomedicine (Figure 1). The current review desolvation during protein folding. Their results suggested that focuses on the bottom-up chemistry and material science the majority of the structural formation is accomplished before considerations of nanomedicine. Implementation of a top- water is expelled from the hydrophobic core. In another study, the Bustamante group reported that chain topology impacted the down method for nanomedicine development is beyond the 30 scope of the current review. cooperative folding of proteins. They used an optical tweezer method to selectively unfold specific regions of T4 lysozymes 2. CONFORMATION CHANGE-INDUCED and monitored its perturbation on other regions. Results showed COOPERATIVITY IN NATURAL SELF-ASSEMBLED the topological arrangement of the polypeptide chain is critical in determining the folding cooperativity. Data indicated that NANOSTRUCTURES cooperative interactions among protein domains depend not Cooperativity is frequently employed in biology to modulate only on the local interactions between amino acids but also on molecular recognition through sequential binding events, usually the degree of complementary shape and topography of the operated by the conformational changes of the macro- polypeptide chains. 5360 DOI: 10.1021/acs.chemrev.8b00195 Chem. Rev. 2018, 118,
Recommended publications
  • Nucleosome-Mediated Cooperativity Between Transcription Factors
    Nucleosome-mediated cooperativity between transcription factors Leonid A. Mirny1 Harvard–MIT Division of Health Sciences and Technology, and Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139 Edited* by José N. Onuchic, University of California San Diego, La Jolla, CA, and approved October 12, 2010 (received for review December 3, 2009) Cooperative binding of transcription factors (TFs) to promoters and A B other regulatory regions is essential for precise gene expression. The classical model of cooperativity requires direct interactions between TFs, thus constraining the arrangement of TF sites in reg- ulatory regions. Recent genomic and functional studies, however, demonstrate a great deal of flexibility in such arrangements with variable distances, numbers of sites, and identities of TF sites lo- cated in cis-regulatory regions. Such flexibility is inconsistent with L C N O D T R cooperativity by direct interactions between TFs. Here, we demon- P 0 0 0 0 P O O strate that strong cooperativity among noninteracting TFs can be K K 2 2 NN O O T R achieved by their competition with nucleosomes. We find that the P 1 1 P 1 1 K O O mechanism of nucleosome-mediated cooperativity is analogous to c = O 10 1..10 3 2 2 K cooperativity in another multimolecular complex: hemoglobin. This N N2 O2 T R [P] P 2 2 = 15 P surprising analogy provides deep insights, with parallels between O2 O2 KO … … the heterotropic regulation of hemoglobin (e.g., the Bohr effect) [N ] L = 0 100 1000 N O and the roles of nucleosome-positioning sequences and chromatin [O0] n n T4 R4 modifications in gene expression.
    [Show full text]
  • Supramolecular Chemistry
    Supramolecular Chemistry Rohit Kanagal Introduction Supramolecular Chemistry is one of the most rapidly growing areas of chemistry. This branch of chemistry emphasises on ‘chemistry beyond the molecule’ and ‘chemistry of molecular assemblies and the intermolecular bond’. Supramolecular Chemistry lends the idea of how molecules interact with one another. It aims to understand the structural and functional properties of systems that contain more than one molecular assembly. Phenomena such as molecular self-assembly, protein folding, molecular recognition, host-guest chemistry, mechanically-interlocked molecular architectures, and dynamic covalent chemistry are all integral parts of Supramolecular chemistry. These phenomena are controlled by certain non- covalent interactions between molecules such as ion-dipole, dipole-dipole interactions, van der Waals forces, hydrogen bonding, metal coordination, hydrophobic forces, pi-pi interactions, and various electrostatic effects. Over the last few decades, the ideas and studies of supramolecular chemistry have entered multiple fields such as chemical science, biological science, physical science, and material science. (Hasenknopf) An example of a supramolecular assembly Superamolecule A supramolecule or supramolecular assembly is a well-defined system of molecules that are held together with non-covalent intermolecular forces to form a bigger unit having its own organization, stability and tendency to associate or isolate. These are formed through the interactions between a molecule having convergent binding sites (such as hydrogen bond donor atoms and a large cavity) and another molecule having divergent binding sites (such as hydrogen bond acceptor atoms). The molecule having convergent binding sites is called host or receptor molecule while the molecule having divergent binding sites is called a guest or analyte molecule.
    [Show full text]
  • Pi-Pi Stacking Mediated Cooperative Mechanism for Human Cytochrome P450 3A4
    Molecules 2015, 20, 7558-7573; doi:10.3390/molecules20057558 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Article Pi-pi Stacking Mediated Cooperative Mechanism for Human Cytochrome P450 3A4 Botao Fa 1, Shan Cong 2 and Jingfang Wang 1,* 1 Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; E-Mail: [email protected] 2 Department of Bioinformatics and Biostatistics, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-21-3420-7344 (ext. 123); Fax: +86-21-3420-4348. Academic Editor: Antonio Frontera Received: 13 January 2015 / Accepted: 19 March 2015 / Published: 24 April 2015 Abstract: Human Cytochrome P450 3A4 (CYP3A4) is an important member of the cytochrome P450 superfamily with responsibility for metabolizing ~50% of clinical drugs. Experimental evidence showed that CYP3A4 can adopt multiple substrates in its active site to form a cooperative binding model, accelerating substrate metabolism efficiency. In the current study, we constructed both normal and cooperative binding models of human CYP3A4 with antifungal drug ketoconazoles (KLN). Molecular dynamics simulation and free energy calculation were then carried out to study the cooperative binding mechanism. Our simulation showed that the second KLN in the cooperative binding model had a positive impact on the first one binding in the active site by two significant pi-pi stacking interactions. The first one was formed by Phe215, functioning to position the first KLN in a favorable orientation in the active site for further metabolism reactions.
    [Show full text]
  • Allosteric Effects and Cooperative Binding
    Biochemistry I, Fall Term Lecture 13 Sept 28, 2005 Lecture 13: Allosteric Effects and Cooperative Binding Assigned reading in Campbell: Chapter 4.7, 7.2 Key Terms: • Homotropic Allosteric effects • Heterotropic Allosteric effects • T and R states of cooperative systems • Role of proximal His residue in cooperativity of O2 binding by Hb • Regulation of O2 binding to Hb by bis-phosphoglycerate (BPG) Oxygen Binding to Myoglobin and Hemolobin: Myoglobin binds one O2: Hemoglobin binds four O2: Allosteric Effects and Cooperativity: Allosteric effects occur when the binding properties of a macromolecule change as a consequence of a second ligand binding to the macromolecule and altering its affinity towards the first, or primary, ligand. There need not be a direct connection between the two ligands (i.e. they may bind to opposite sides of the protein, or even to different subunits) • If the two ligands are the same (e.g. oxygen) then this is called a homo-tropic allosteric effect. • If the two ligands are different (e.g. oxygen and BPG), then this is called a hetero-tropic allosteric effect. In the case of macromolecules that have multiple ligand binding sites (e.g. Hb), allosteric effects can generate cooperative behavior. Allosteric effects are important in the regulation of enzymatic reactions. Both allosteric activators (which enhance activity) and allosteric inhibitors (which reduce activity) are utilized to control enzyme reactions. Allosteric effects require the presence of two forms of the macromolecule. One form, usually called the T or tense state, binds the primary ligand (e.g. oxygen) with low affinity. The other form, usually called the R or relaxed state, binds ligand with high affinity.
    [Show full text]
  • From Supramolecular Chemistry to Nanotechnology: Assembly of 3D Nanostructures*
    Pure Appl. Chem.,Vol. 81, No. 12, pp. 2225–2233, 2009. doi:10.1351/PAC-CON-09-07-04 © 2009 IUPAC, Publication date (Web): 3 November 2009 From supramolecular chemistry to nanotechnology: Assembly of 3D nanostructures* Xing Yi Ling‡, David N. Reinhoudt, and Jurriaan Huskens Molecular Nanofabrication Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands Abstract: Fabricating well-defined and stable nanoparticle crystals in a controlled fashion re- ceives growing attention in nanotechnology. The order and packing symmetry within a nanoparticle crystal is of utmost importance for the development of materials with unique op- tical and electronic properties. To generate stable and ordered 3D nanoparticle structures, nanotechnology is combined with supramolecular chemistry to control the self-assembly of 2D and 3D receptor-functionalized nanoparticles. This review focuses on the use of molecu- lar recognition chemistry to establish stable, ordered, and functional nanoparticle structures. The host–guest complexation of β-cyclodextrin (CD) and its guest molecules (e.g., adaman- tane and ferrocene) are applied to assist the nanoparticle assembly. Direct adsorption of supramolecular guest- and host-functionalized nanoparticles onto (patterned) CD self-as- sembled monolayers (SAMs) occurs via multivalent host–guest interactions and layer-by- layer (LbL) assembly. The reversibility and fine-tuning of the nanoparticle-surface binding strength in this supramolecular assembly scheme are the control parameters in the process. Furthermore, the supramolecular nanoparticle assembly has been integrated with top- down nanofabrication schemes to generate stable and ordered 3D nanoparticle structures, with con- trolled geometries and sizes, on surfaces, other interfaces, and as free-standing structures. Keywords: nanoparticles; nanoparticle arrays; self-assembly; self-assembled monolayer; supramolecular chemistry.
    [Show full text]
  • Mathematical Toolkit for Quantitative Analysis of Cooperative Binding of Two Or More Ligands to a Substrate Jacob Peacock and James B
    Mathematical toolkit for quantitative analysis of cooperative binding of two or more ligands to a substrate Jacob Peacock and James B. Jaynes Dept. of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia PA 19107 United States of America [email protected] Abstract We derive mathematical expressions for quantitative analysis of cooperative binding covering the following cases: 1) a single ligand binds to either two non-equivalent sites, or an arbitrary number of equivalent sites, on a substrate (Fig. 1), and 2) two different ligands bind distinct sites on a substrate (Figs. 2, 3). We show how to analyze "competition experiments" using non-linear regression, where a ligand binds to a single site on a labeled substrate in the presence of increasing amounts of identical but unlabeled competitor substrate, to simultaneously determine the Kd and active ligand concentration (Fig. 4A). We compare the performance of this competition method with the commonly used saturation binding method (Fig. 4B). We also provide methods to analyze such experiments that include a second competitor substrate with non-specific binding sites. We show how to build on results from single-ligand competition experiments to fully characterize cooperative binding in systems with two distinct ligands and binding sites (Fig. 4C and Section 5). We generalize the methodology to more than two cooperating ligands, such as an array of DNA binding proteins (Fig. 6). See Peacock and Jaynes [1] for discussion of the various ways these tools can be used, and results using them. • Visualize characteristics and limitations of Hill plots applied to more realistic binding models than those described by the Hill equation, which implies multiple simultaneous ligand binding.
    [Show full text]
  • Deep Profiling of Protease Substrate Specificity Enabled by Dual Random and Scanned Human Proteome Substrate Phage Libraries
    Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries Jie Zhoua, Shantao Lib, Kevin K. Leunga, Brian O’Donovanc, James Y. Zoub,d, Joseph L. DeRisic,d, and James A. Wellsa,d,e,1 aDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; bDepartment of Biomedical Data Science, Stanford University, Stanford, CA 94305; cDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158; dChan Zuckerberg Biohub, San Francisco, CA 94158; and eDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158 Edited by Benjamin F. Cravatt, Scripps Research Institute, La Jolla, CA, and approved August 19, 2020 (received for review May 11, 2020) Proteolysis is a major posttranslational regulator of biology inside lysate and miss low abundance proteins and those simply not and outside of cells. Broad identification of optimal cleavage sites expressed in cell lines tested that typically express only half their and natural substrates of proteases is critical for drug discovery genomes (13). and to understand protease biology. Here, we present a method To potentially screen a larger and more diverse sequence that employs two genetically encoded substrate phage display space, investigators have developed genetically encoded substrate libraries coupled with next generation sequencing (SPD-NGS) that phage (14, 15) or yeast display libraries (16, 17). Degenerate DNA allows up to 10,000-fold deeper sequence coverage of the typical six- sequences (up to 107) encoding random peptides were fused to a to eight-residue protease cleavage sites compared to state-of-the-art phage or yeast coat protein gene for a catch-and-release strategy synthetic peptide libraries or proteomics.
    [Show full text]
  • Supramolecular Assembly of DNA-Phenanthrene Conjugates Into Vesicles with Light-Harvesting Properties Caroline D
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Bern Open Repository and Information System (BORIS) Supramolecular Assembly of DNA-Phenanthrene Conjugates into Vesicles with Light-Harvesting Properties Caroline D. Bösch, Jovana Jevric, Nutcha Bürki, Markus Probst, Simon M. Langenegger, and Robert Häner* Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland Supporting Information Placeholder ABSTRACT : Vesicle-shaped supramolecular polymers are formed by self-assembly of a DNA duplex containing phenanthrene overhangs at both ends. In presence of spermine, the phenanthrene overhangs act as sticky ends linking the DNA duplexes together. In aqueous solution, the assembly leads to vesicles in the range of 50 – 200 nm, as shown by electron microscopy and dynamic light scattering. Fluorescence measurements show that the assembled phenanthrene units act as light-harvesting antennae and transfer absorbed energy to an acceptor, such as pyrene or Cy3, which can either be directly added to the polymer or attached via a complementary DNA strand. The presence of DNA in the nanostructures allows the con- struction of light-harvesting vesicles that are amenable to functionalization with different chemical groups. DNA is used to create one-, two-, or three-dimensional assemblies phodiester groups. Hybridization leads to the formation of DNA du- due to its unique molecular recognition properties which opens oppor- plex 1*2 containing three phenanthrenes at each end. Oligonucleotides tunities to precisely organize functional groups within space.1-9 Func- 3 and 4 serve as unmodified control sequences. tional supramolecular assemblies of DNA object have a potential for biomedical, biomimetic and electronic applications.10-18 DNA Table 1.
    [Show full text]
  • Acetic Acid (Activator-3) Is a Potent Activator of AMPK
    www.nature.com/scientificreports OPEN 2-[2-(4-(trifuoromethyl) phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent Received: 29 June 2017 Accepted: 6 June 2018 activator of AMPK Published: xx xx xxxx Navneet Bung1, Sobhitha Surepalli2, Sriram Seshadri3, Sweta Patel3, Saranya Peddasomayajula2, Lalith Kumar Kummari 2,5,6, Sireesh T. Kumar4, Phanithi Prakash Babu4, Kishore V. L. Parsa2, Rajamohan Reddy Poondra2, Gopalakrishnan Bulusu1,2 & Parimal Misra2 AMPK is considered as a potential high value target for metabolic disorders. Here, we present the molecular modeling, in vitro and in vivo characterization of Activator-3, 2-[2-(4-(trifuoromethyl) phenylamino)thiazol-4-yl]acetic acid, an AMP mimetic and a potent pan-AMPK activator. Activator-3 and AMP likely share common activation mode for AMPK activation. Activator-3 enhanced AMPK phosphorylation by upstream kinase LKB1 and protected AMPK complex against dephosphorylation by PP2C. Molecular modeling analyses followed by in vitro mutant AMPK enzyme assays demonstrate that Activator-3 interacts with R70 and R152 of the CBS1 domain on AMPK γ subunit near AMP binding site. Activator-3 and C2, a recently described AMPK mimetic, bind diferently in the γ subunit of AMPK. Activator-3 unlike C2 does not show cooperativity of AMPK activity in the presence of physiological concentration of ATP (2 mM). Activator-3 displays good pharmacokinetic profle in rat blood plasma with minimal brain penetration property. Oral treatment of High Sucrose Diet (HSD) fed diabetic rats with 10 mg/kg dose of Activator-3 once in a day for 30 days signifcantly enhanced glucose utilization, improved lipid profles and reduced body weight, demonstrating that Activator-3 is a potent AMPK activator that can alleviate the negative metabolic impact of high sucrose diet in rat model.
    [Show full text]
  • Supramolecular Assemblies of Cucurbiturils with Photoactive, Π
    Review 1 DOI: 10.1002/ijch.201700114 2 3 4 Supramolecular Assemblies of Cucurbiturils with 5 Photoactive, -conjugated Chromophores 6 p 7 [a] [a, b] 8 Ahmet Koc and Do¨nu¨s Tuncel* 9 10 11 Abstract: Supramolecular assemblies of cucurbituril (CBn) polymers. How supramolecular complexes of p-conjugated 12 homologues with p-conjugated chromophores will be over- chromophores including porphyrin derivatives, conjugated 13 viewed. Special emphasis will be given to the effect of CBn oligomers and polymers with CBn could be utilized in the 14 on the optical properties of conjugated oligomers and theranostic and photonic applications will also be discussed. 15 Keywords: Cucurbiturils · supramolecular assemblies · p-conjugated chromophores · porphyrins · conjugated polymers 16 17 18 1. Introduction 10 glycoluril units, respectively.[9] The new members of CB 19 family that shows remarkable differences in their cavity sizes, 20 In this review, we are going to discuss the supramolecular guest binding affinities, size selectivity and water-solubility 21 assemblies of cucurbituril (CBn) homologues with photo- attracted huge interest by the supramolecular chemists.[10] 22 active, conjugated chromophores. Photoactive, p-conjugated Among them, CB7, with good water solubility, appropriate 23 chromophores have many important applications in the areas guest size selectivity and binding affinity, have been the most 24 of sensing, catalysis, lasers, imaging, theranostics and pho- in demand up to now. 25 tonics.[1–6] However, there are some drawbacks that should be Compared to other well-known macrocyclic host mole- 26 overcome in order to utilize them in a wider context including cules such as cyclodextrins, calixarenes and crown ethers, CBs 27 stability (chemical, thermal, photo), solubility, poor optical not only exhibit the similar low-toxic nature, but they also 28 performance (low quantum yields, low lifetime) due to offer much higher chemical stability and far better guest 29 aggregation.
    [Show full text]
  • Understanding the Structure and Function of Catalases: Clues from Molecular Evolution and in Vitro Mutagenesis
    PERGAMON Progress in Biophysics & Molecular Biology 72 (1999) 19±66 Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis Marcel Za mocky *, Franz Koller Institut fuÈr Biochemie and Molekulare Zellbiologie and Ludwig Boltzmann Forschungsstelle fuÈr Biochemie, Vienna Biocenter, Dr. Bohr-Gasse 9, A-1030 Wien, Austria Abstract This review gives an overview about the structural organisation of dierent evolutionary lines of all enzymes capable of ecient dismutation of hydrogen peroxide. Major potential applications in biotechnology and clinical medicine justify further investigations. According to structural and functional similarities catalases can be divided in three subgroups. Typical catalases are homotetrameric haem proteins. The three-dimensional structure of six representatives has been resolved to atomic resolution. The central core of each subunit reveals a chracteristic ``catalase fold'', extremely well conserved among this group. In the native tetramer structure pairs of subunits tightly interact via exchange of their N- terminal arms. This pseudo-knot structures implies a highly ordered assembly pathway. A minor subgroup (``large catalases'') possesses an extra ¯avodoxin-like C-terminal domain. A r25AÊ long channel leads from the enzyme surface to the deeply buried active site. It enables rapid and selective diusion of the substrates to the active center. In several catalases NADPH is tightly bound close to the surface. This cofactor may prevent and reverse the formation of compound II, an inactive reaction intermediate. Bifunctional catalase-peroxidases are haem proteins which probably arose via gene duplication of an ancestral peroxidase gene. No detailed structural information is currently available. Even less is know about manganese catalases.
    [Show full text]
  • Drug Conjugates Based on a Monovalent Affibody Targeting
    cancers Article Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model Tianqi Xu 1,† , Haozhong Ding 2,† , Anzhelika Vorobyeva 1,3 , Maryam Oroujeni 1, Anna Orlova 3,4 , Vladimir Tolmachev 1,3 and Torbjörn Gräslund 2,* 1 Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden; [email protected] (T.X.); [email protected] (A.V.); [email protected] (M.O.); [email protected] (V.T.) 2 Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, 114 17 Stockholm, Sweden; [email protected] 3 Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia; [email protected] 4 Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden * Correspondence: [email protected]; Tel.: +46-(0)8-790-96-27 † Equal contribution. Simple Summary: Drug conjugates, consisting of a tumor targeting part coupled to a highly toxic molecule, are promising for treatment of many different types of cancer. However, for many patients it is not curative, and investigation of alternative or complimentary types of drug conjugates is motivated. Here, we have devised and studied a novel cancer cell-directed drug conjugate ZHER2:2891- ABD-E3-mcDM1. We found that it could induce efficient shrinkage and, in some cases, complete Citation: Xu, T.; Ding, H.; Vorobyeva, regression of human tumors implanted in mice, and thus holds promise to become a therapeutic A.; Oroujeni, M.; Orlova, A.; agent for clinical use in the future.
    [Show full text]